Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Urogenital Neoplasms × Powders × Clear all

Phase

Status

Terminated 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Urogenital Neoplasms 1 Genital Neoplasms, Male 1

Interventions

valrubicin 1 ixabepilone 1 ferumoxtran-10 1 atezolizumab 1 Suspensions 1 Sunitinib 1 Standard of Care 1 Powders 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Drug Therapy 1 BAY 86-7548 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04221828 2022-03-29

Trial of NanoPac Focal Therapy for Prostate Cancer

NanOlogy, LLC

Phase 2 Terminated

1 enrolled 5 charts

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡